https://scholars.lib.ntu.edu.tw/handle/123456789/583863
Title: | Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells | Authors: | Chen J.-C. JEN-CHANG KO Taso Y.-C. Cheng H.-H. Chen T.-Y. Yen T.-C. Lin Y.-W. |
Issue Date: | 2021 | Publisher: | S. Karger AG | Journal Volume: | 106 | Journal Issue: | 44259 | Start page/Pages: | 154-168 | Source: | Pharmacology | Abstract: | Introduction: Xeroderma pigmentosum complementation group C (XPC) protein is an important DNA damage recognition factor involved in nucleotide excision repair and regulation of non-small-cell lung cancer (NSCLC) cell proliferation and viability. 17-Allyla |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096700841&doi=10.1159%2f000509052&partnerID=40&md5=d61fe3cc4150c45ab89eb56b211cb2b5 https://scholars.lib.ntu.edu.tw/handle/123456789/583863 |
ISSN: | 0031-7012 | DOI: | 10.1159/000509052 | SDG/Keyword: | bevacizumab; protein kinase B; tanespimycin; xeroderma pigmentosum group C protein; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; angiogenesis inhibitor; antineoplastic agent; benzoquinone derivative; bevacizumab; chromone derivative; DNA binding prot |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.